Company Description
Cardio Diagnostics Holdings (NASDAQ: CDIOW) is classified in the In Vitro & in Vivo Diagnostic Substances sector.
CDIOW has gained 16.4% over the past year. Shares last traded at $0.0170.
For FY2025, Cardio Diagnostics Holdings reported revenue of $15K with net income of -$6.5M and diluted earnings per share of $-3.71. The company operates at a net profit margin of -43832.5%.
This page collects what Stock Titan holds for CDIOW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cardio Diagnostics Holdings (CDIOW) stock last closed at $0.0170. Over the past 12 months, the stock has gained 16.4%.
CDIOW Rankings
Latest News
SEC Filings
Cardio Diagnostics Holdings has filed 5 recent SEC filings, including 4 Form 4, 1 Form DEF 14A. The most recent filing was submitted on August 5, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CDIOW SEC filings →
Financial Highlights
Cardio Diagnostics Holdings generated $15K in revenue in FY2025, operating income reached -$6.5M (-43737.5% operating margin), and net income was -$6.5M, reflecting a -43832.5% net profit margin. Diluted earnings per share stood at $-3.71. The company generated -$5.7M in operating cash flow. With a current ratio of 9.79, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Cardio Diagnostics Holdings (CDIOW) currently stands at 4.4 thousand shares, up 64.3% from the previous reporting period. Since August 2025, short interest has increased by 98.6%.
Days to Cover History
Days to cover for Cardio Diagnostics Holdings (CDIOW) currently stands at 1.0 days, down 62% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 9.8 days.
CDIOW Company Profile & Sector Positioning
Cardio Diagnostics Holdings (CDIOW) operates in the In Vitro & in Vivo Diagnostic Substances sector and is listed on the NASDAQ.